Pharmacy Medical News about Osteoarthritis, Hip Osteoarthritis, Knee Doxycycline

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Statins and cancer risk

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Doxycycline for osteoarthritis of the knee or hip
Cochrane Reviews, 10/23/09

Nuesch E et al. – The symptomatic benefit of doxycycline is minimal to non–existent. The small benefit in terms of joint space narrowing is of questionable clinical relevance and outweighed by safety problems. Doxycycline should not be recommended for the treatment of osteoarthritis of the knee or hip.

<< Previous
Randomized study to compare valsartan ± HCTZ versus amlodipine ±...

Next >>
Romiplostim in chronic immune thrombocytopenic purpura

S-Adenosylmethionine for osteoarthritis of the knee or hip
Cochrane Reviews, 10/22/09 Relevance Score: 90%

Knee and Hip Radiographic Osteoarthritis Predict Total Hip Bone Loss in Older Adults: A Prospective Study
Journal of Bone and Mineral Research, 10/16/09 Relevance Score: 90%

Correlates of Pain Intensity in Men and Women With Hip and Knee Osteoarthritis. Results of a National Survey: The French ARTHRIX Study
The Clinical Journal of Pain, 10/23/09 Relevance Score: 89%

Oral or transdermal opioids for osteoarthritis of the knee or hip
Cochrane Reviews, 10/13/09 Relevance Score: 89%

Osteoarthritis: A review of treatment options
Geriatrics, 10/21/09 Relevance Score: 88%